FDA issued a Warning Letter to Pine Pharmaceuticals, LLC on 11/7/2016 for a previous inspection.
483 Pine Pharmaceuticals Apr 2018

483 Pine Pharmaceuticals Apr 2018

Rachael Moliver FDA$119.00 - Available Now

FDA investigators audited the Pine Pharmaceuticals - Tonawanda, NY, United States facility and issued inspectional observations (via FDA 483) on 26 Apr 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Apr 2018
  • Location: Tonawanda, United States
  • FEI: 3010943533
Add To Cart